WSWenbing Sheng

Wenbing Sheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wenbing Sheng has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Wang

    TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Material Medical Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China

    7 shared publications
  • Jingmin Chen

    Hunan University of Chinese Medicine

    4 shared publications
  • Jia Li

    School of Pharmacy Hunan University of Chinese Medicine Changsha 410208 China

    3 shared publications
  • Xudong Zhou

    School of Pharmacy Hunan University of Chinese Medicine Changsha 410208 China

    3 shared publications
  • Yangyang Li

    Hunan University of Chinese Medicine

    3 shared publications
  • Atta- Ur- Rahman

    H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan

    2 shared publications

Latest Publications

  • Open Access

    Rhodium-Catalyzed N -Allylation of Sulfoximines Using Alkyl Alkynes

    by Jingmin Chen, Yunxi Zhang, Xiangyu Lin, Yang Zhang, Caiyun Peng, Wei Wang, Yangyang Li, Wenbing Sheng

    Rhodium-catalyzed N-allylation coupling reactions of sulfoximines with alkyl alkynes have been reported. The branched allylic products were obtained with a rhodium catalyst under mild reaction conditions and provided good to excellent yields of N-allylic sulfoximines. This protocol provides efficient access to diverse N-allylic sulfoximine derivatives, showing broad functional group compatibility and substantial substrate scope.


  • Recent Advances in the Synthesis and N ‐Functionalization of Sulfonimidamides

    by Jingmin Chen, Yangyang Li, Jia Li, Jie Tao, Xudong Zhou, Wei Wang, Wenbing Sheng

    Sulfonimidamides (SIAs) have garnered broad interests from medicinal chemists owing to their diverse and broad spectrum biological activities. This class of organosulfur compounds has also demonstrated promising applications in agriculture and materials science. In order to obtain structurally diverse SIAs and their N ‐functionalized derivatives, a variety of synthetic methodologies have been developed. This review highlights the key discoveries and recent advances in this dynamic and rapidly evolving research field over the past decade. The synthetic approaches for SIAs include conventional synthetic methods, photocatalytic synthesis, transition metal‐catalyzed reactions, mechanochemical strategies, and SuFEx chemistry. Meanwhile, the N ‐functionalization reactions encompass N‐ aliphatic alkylation, N ‐acylation, N ‐arylation, and N ‐sulfenylation. The challenges of N ‐functionalization and outlooks on the application of SIAs are also concluded in this review.


  • Synthesis and Biological Activity of Benzoselenazole and Benzo[b]Selenophene Analogues: A Review

    by Jia Li, Jingmin Chen, Jiayao Liu, Xudong Zhou, Yangyang Li, Wei Wang, Wenbing Sheng

    Selenium, an essential micronutrient in the human body, not only exhibits potent antioxidant properties but also plays a critical role in regulating thyroid hormone metabolism, maintaining normal immune function, and inhibiting tumour progression. Among selenium‐containing compounds, ebselen is the most extensively studied drug candidate. Research has shown that various derivatives obtained through structural modifications of Ebselen exhibits significant biological activities; however, these compounds have yet to progress to clinical trials. Consequently, selenium‐containing heterocyclic compounds represent a promising avenue for drug discovery and development. This review summarizes three synthetic approaches for constructing selenium‐containing heterocyclic compounds and emphasizes their notable biological activities and potential applications in pharmaceuticals.


  • Open Access

    Design, synthesis and biological activity of novel Xuetongsu derivatives as potential anticancer agents by inducing apoptosis

    by Qi Jiang, Hui Zhong, Cong Wu, Jia Li, Jingmin Chen, Xudong Zhou, Bin Li, Huanghe Yu, Wei Wang, Wenbing Sheng

    Xuetongsu (XTS, Schisanlactone E) is one of the main active compounds and considered as the star molecule isolated from Kadsura heteroclita (Roxb.) Craib. In order to improve XTS anti-tumour bioactivities, a series of novel XTS derivatives were designed and synthesised by introducing an amide bond at the parent. Anti-proliferative assays on four different human tumour cell lines (BGC-823, HepG-2, HCT-116, and MCF-7) showed that the anti-tumour activities of most derivatives increased greatly compared to the parent XTS, and especially, compounds A-7, A-14, and A-18 exhibited multiple anti-tumour effects. Among them, compound A-7 has the best biological activities on the four tumour cell lines with the IC50 values ranging from 13.86 to 20.71 μM, which could significantly increase the fraction of apoptotic cells according to flow cytometry experience. Further study demonstrated that A-7 could induce apoptosis on HepG-2 cells through influencing the key apoptotic related proteins, such as Bcl-2, Bax, and cleaved Caspase-3.


  • Open Access

    Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus

    by Cong Wu, Qi Jiang, Hui Zhong, Xudong Zhou, Leping Liu, Tong Pan, Chao Liu, Wei Wang, Wenbing Sheng

    An oxidising and substituting one-pot reaction strategy has been developed to synthesise dihydromyricetin derivatives with the aim of enhancing the inhibitory activity of dihydromyricetin against SARS-CoV-2. Different ω-methoxy-ω-oxeylkyl was introduced in C7-OH site and yielded eight analogs, all of them showed good inhibitory activity against SARS-CoV-2 3CLpro with IC50 values ranging from 0.72 to 2.36 μM. In the Vero E6-cell, compound 3 has a good activity of anti-SARS-CoV-2 virus (Omicron virus BA.5) in the prevention model, with an EC50 of 15.84 μM, and so do compound 10 in the therapeutic model, with an EC50 of 11.52 μM. The results suggest that the introduction of long chain ω-oxeylkyl at C7-OH facilitate the inhibition of viral replication in the therapeutic model, which is consistent with the binding energies predicted from molecular docking conclusions. It implies that dihydromyricetin derivatives have the potential to become effective inhibitors of SARS-CoV-2 Omicron and other viruses.


  • Open Access

    Design, Synthesis, and Antitumor Activity Evaluation of Artemisinin Bivalent Ligands

    by Hui Zhong, Qi Jiang, Cong Wu, Huanghe Yu, Bin Li, Xudong Zhou, Ronggeng Fu, Wei Wang, Wenbing Sheng

    Five artemisinin bivalent ligands molecules 4a–4e were designed, synthesized, and confirmed by 1H NMR, 13C NMR, and low-resolution mass spectrometry, and the bioactivities of the target compounds were investigated against four human tumor cell lines in vitro, including BGC-823, HepG-2, MCF-7, and HCT-116. The results showed 4a, 4d, and 4e exhibited significantly tumor cell inhibitory activity compared with the artemisinin and dihydroartemisinin; compound 4e has good biological activity inhibiting BGC-823 with an IC50 value of 8.30 μmol/L. Then, the good correlations with biological results were validated by molecular docking through the established bivalent ligands multi-target model, which showed that 4e could bind well with the antitumor protein MMP-9.


  • Schinortriterpenoids from Tujia ethnomedicine Xuetong—The stems of Kadsura heteroclita

    by Liang Cao, Nuzhat Shehla, Bin Li, Yuqing Jian, Caiyun Peng, Wenbing Sheng, Leping Liu, Xiong Cai, Rongyong Man, Duan-Fang Liao, et al.


  • Open Access

    New Cadinane Sesquiterpenes from the Stems of Kadsura heteroclita

    by Liang Cao, Nuzhat Shehla, Shumaila Tasneem, Mengru Cao, Wenbing Sheng, Yuqing Jian, Bin Li, Caiyun Peng, M. Iqbal Choudhary, Atta- Ur- Rahman, et al.

    As part of our continual efforts to exploit ‘Tujia Ethnomedicine’ for their pharmacophoric functionalities, we herein investigated Kadsura heteroclita collected from a deep Wulin mountain area in northern Hunan province. The current study resulted in the isolation of three new sesquiterpenes: 6α,9α,15-trihydroxycadinan-4-en-3-one (1), (+)-3,11,12-trihydroxycalamenene (2), (–)-3,10,11,12-tetrahydroxy-calamenene (3), along with four known sesquiterpenes (4–7), and a cytochalasin H (8). Their chemical structures were elucidated by 1D-, and 2D-NMR spectroscopy, and HRESI-MS, CD spectrometry. The antioxidant, and cytotoxic activities of the compounds were evaluated. Compound 8 exhibited a strong antioxidant effect with an IC50 value of 3.67 µM on isolated human polymorphonuclear cells or neutrophils.


  • ChemInform Abstract: Metal‐Free Direct Cyanoisopropylation/Arylation of N‐Arylacrylamides or N‐Alkyl‐N‐(arylsulfonyl)acrylamides with AIBN: A Simple and Mild Approach to Cyano‐Containing Oxindoles.

    by Mingzhong Zhang, Wenbing Sheng, Pengyi Ji, Yufeng Liu, Cancheng Guo

    A simple and metal‐free direct cyanoisopropylation/arylation of N‐arylacrylamides and N‐alkyl‐N‐(arylsulfonyl)acrylamides with AIBN is developed using MeNO2 as both solvent and oxidant.